Brain signal intensity changes as biomarkers in amyotrophic lateral sclerosis

Juan F Vázquez-Costa1,2,3, Miguel Mazón4, Joan Carreres-Polo4

  • 1Neuromuscular Research Unit, Instituto de Investigación Sanitaria la Fe, Valencia, Spain.

Abstract

Insights

Iron-related hypointensities in the motor cortex and hyperintensities of the corticospinal tract are reliable markers of neurodegeneration in amyotrophic lateral sclerosis (ALS). These MRI findings are more common in bulbar onset patients and can indicate disease progression.

Area of Science:

  • Neurology
  • Radiology
  • Genetics

Background:

  • Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease.
  • Brain MRI signal intensity changes may reflect underlying pathology.

Purpose of the Study:

  • To evaluate demographic, clinical, analytical, and genetic factors influencing T2-weighted MRI signal intensity changes in ALS patients and controls.
  • To determine the utility of specific MRI markers in ALS.

Main Methods:

  • Susceptibility-weighted and FLAIR MRI sequences were acquired.
  • Iron-related hypointensities in the motor cortex (IRhMC) and hyperintensities of the corticospinal tract (HCT) were scored.
  • Genetic testing (C9orf72, SOD1) and clinical data were analyzed.

Main Results:

  • In ALS patients, both IRhMC and HCT correlated with upper motor neuron (UMN) impairment and bulbar onset.
  • The extent of IRhMC mapped to the motor homunculus corresponded to symptom onset location.
  • No significant differences in IRhMC and HCT were observed between genetic and sporadic ALS patients.

Conclusions:

  • IRhMC and HCT are dependable indicators of UMN degeneration in ALS, irrespective of genetic status.
  • Bulbar onset ALS patients exhibit these MRI changes more frequently.
  • Regional IRhMC measurements may serve as a biomarker for ALS disease progression.